The effect of selective serotonin reuptake inhibitors in healthy subjects revisited: A systematic review of the literature.

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis

Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32802-7 · Cited by 3,541 · see citing works

Increased Positive Versus Negative Affective Perception and Memory in Healthy Volunteers Following Selective Serotonin and Norepinephrine Reuptake Inhibition

Harmer, C. J., Shelley, N. C., Cowen, P. J., & Goodwin, G. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1256 · Cited by 554 · see citing works

Selective Alteration of Personality and Social Behavior by Serotonergic Intervention

Knutson, B., Wolkowitz, O. M., Cole, S. W., Chan, T., Moore, E. A., Johnson, R. C., Terpstra, J., Turner, R. A., & Reus, V. I. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.3.373 · Cited by 500 · see citing works

Antidepressant Drug Treatment Modifies the Neural Processing of Nonconscious Threat Cues

Harmer, C. J., Mackay, C. E., Reid, C. B., Cowen, P. J., & Goodwin, G. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.015 · Cited by 450 · see citing works

Biomarkers for depression: recent insights, current challenges and future prospects

Strawbridge, R., Young, A. H., & Cleare, A. J. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s114542 · Cited by 415 · see citing works

Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment

McCabe, C., Mishor, Z., Cowen, P. J., & Harmer, C. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.11.001 · Cited by 365 · see citing works

Sex differences in the psychopharmacological treatment of depression

Sramek, J. J., Murphy, M. F., & Cutler, N. R. (2016) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2016.18.4/ncutler · Cited by 334 · see citing works

Salivary cortisol in depressed patients versus control persons: A systematic review and meta-analysis

Knorr, U., Vinberg, M., Kessing, L. V., & Wetterslev, J. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.04.001 · Cited by 317 · see citing works

Paroxetine decreases platelet serotonin storage and platelet function in human beings

Hergovich, N. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.110456 · Cited by 231 · see citing works

Hormonal Response Pattern in the Combined DEX-CRH Test Is Stable over Time in Subjects at High Familial Risk for Affective Disorders

Modell, S. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00144-9 · Cited by 208 · see citing works

Escitalopram effects on insula and amygdala BOLD activation during emotional processing

Arce, E., Simmons, A. N., Lovero, K. L., Stein, M. B., & Paulus, M. P. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1004-8 · Cited by 198 · see citing works

Antidepressant medications reduce subcortical-cortical resting-state functional connectivity in healthy volunteers

McCabe, C., & Mishor, Z. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.05.051 · Cited by 184 · see citing works

Early changes in emotional processing as a marker of clinical response to SSRI treatment in depression

Godlewska, B. R., Browning, M., Norbury, R., Cowen, P. J., & Harmer, C. J. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.130 · Cited by 181 · see citing works

Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects

Gerdelat-Mas, A., Loubinoux, I., Tombari, D., Rascol, O., Chollet, F., & Simonetta-Moreau, M. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.05.009 · Cited by 131 · see citing works

The effects of paroxetine and nefazodone on sleep: a placebo controlled trial

Sharpley, A. L., Williamson, D. J., Attenburrow, M. E. J., Pearson, G., Sargent, P. A., & Cowen, P. J. (1996) · Psychopharmacology · doi:10.1007/bf02246410 · Cited by 120 · see citing works

Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: A randomized cross-over study

Windischberger, C., Lanzenberger, R., Holik, A., Spindelegger, C., Stein, P., Moser, U., Gerstl, F., Fink, M., Moser, E., & Kasper, S. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2009.10.013 · Cited by 114 · see citing works

Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors

Schmitt, J. A. J., Kruizinga, M. J., & Riedel, W. J. (2001) · Journal of Psychopharmacology · doi:10.1177/026988110101500304 · Cited by 114 · see citing works

Short-term antidepressant treatment modulates amygdala response to happy faces

Norbury, R., Taylor, M. J., Selvaraj, S., Murphy, S. E., Harmer, C. J., & Cowen, P. J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1597-1 · Cited by 109 · see citing works

Effects of sertraline on autonomic and cognitive functions in healthy volunteers

Siepmann, M., Grossmann, J., M�ck-Weymann, M., & Kirch, W. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1448-4 · Cited by 104 · see citing works

A comparative study of acute and subchronic effects of dothiepin, fluoxetine and placebo on psychomotor and actual driving performance.

Ramaekers, J., Muntjewerff, N., & O'Hanlon, J. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb04468.x · Cited by 104 · see citing works

Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs

Bismuth-Evenzal, Y., Gonopolski, Y., Gurwitz, D., Iancu, I., Weizman, A., & Rehavi, M. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.013 · Cited by 101 · see citing works

Actual Driving Performance and Psychomotor Function in Healthy Subjects After Acute and Subchronic Treatment With Escitalopram, Mirtazapine, and Placebo

Wingen, M., Bothmer, J., Langer, S., & Ramaekers, J. G. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0405 · Cited by 97 · see citing works

Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale

Montejo, A. L., Prieto, N., Terleira, A. I., Matias, J., Alonso, S., Paniagua, G., Naval, S., Parra, D., Gabriel, C., Mocaër, E., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108096507 · Cited by 97 · see citing works

Acute and subchronic effects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers

Robbe, H. W. J. (1995) · European Neuropsychopharmacology · doi:10.1016/0924-977x(94)00130-4 · Cited by 93 · see citing works

Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers

Murphy, S. E., Yiend, J., Lester, K. J., Cowen, P. J., & Harmer, C. J. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009164 · Cited by 90 · see citing works

Two-Week Treatment With the Selective Serotonin Reuptake Inhibitor Citalopram Reduces Contextual Anxiety but Not Cued Fear in Healthy Volunteers: A Fear-Potentiated Startle Study

Grillon, C., Chavis, C., Covington, M. F., & Pine, D. S. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.141 · Cited by 88 · see citing works

Central 5-HT4 receptor binding as biomarker of serotonergic tonus in humans: a [11C]SB207145 PET study

Haahr, M. E., Fisher, P. M., Jensen, C. G., Frokjaer, V. G., Mahon, B. M., Madsen, K., Baaré, W. F. C., Lehel, S., Norremolle, A., Rabiner, E. A., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.147 · Cited by 86 · see citing works

Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans

Chial, H. J., Camilleri, M., Ferber, I. J., Delgado-Aros, S., Burton, D. D., McKinzie, S., & Zinsmeister, A. R. (2003) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(03)70038-x · Cited by 84 · see citing works

Neural Correlates of Antidepressant-Related Sexual Dysfunction: A Placebo-Controlled fMRI Study on Healthy Males Under Subchronic Paroxetine and Bupropion

Abler, B., Seeringer, A., Hartmann, A., Grön, G., Metzger, C. D., Walter, M., & Stingl, J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.66 · Cited by 83 · see citing works

Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer

Loubinoux, I., Tombari, D., Pariente, J., Gerdelat-Mas, A., Franceries, X., Cassol, E., Rascol, O., Pastor, J., & Chollet, F. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2004.12.023 · Cited by 82 · see citing works

Short-term antidepressant administration reduces negative self-referential processing in the medial prefrontal cortex in subjects at risk for depression

Simplicio, M. C. D., Norbury, R., & Harmer, C. J. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.16 · Cited by 82 · see citing works

Subchronic SSRI administration reduces insula response during affective anticipation in healthy volunteers

Simmons, A. N., Arce, E., Lovero, K. L., Stein, M. B., & Paulus, M. P. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990149 · Cited by 80 · see citing works

Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment

Riedel, W. J., Eikmans, K., Heldens, A., & Schmitt, J. A. J. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105048887 · Cited by 73 · see citing works

Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man

Schmitt, J. A. J., Ramaekers, J. G., Kruizinga, M. J., van Boxtel, M. P. J., Vuurman, E. F. P. M., & Riedel, W. J. (2002) · Journal of Psychopharmacology · doi:10.1177/026988110201600303 · Cited by 69 · see citing works

Are there meaningful biomarkers of treatment response for depression?

Breitenstein, B., Scheuer, S., & Holsboer, F. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.02.002 · Cited by 69 · see citing works

Are there depression and anxiety genetic markers and mutations? A systematic review

Lacerda-Pinheiro, S. D. F., Pinheiro, R. F. F., de Lima, M. A. P., da Silva, C. G. L., dos Santos, M. D. S. V., Júnior, A. G. T., de Oliveira, P. N. L., Ribeiro, K. D. B., Neto, M. L. R., & Bianco, B. A. V. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.07.016 · Cited by 69 · see citing works

Paradoxical effects of short-term antidepressant treatment in fMRI emotional processing models in volunteers with high neuroticism

Simplicio, M. C. D., Norbury, R., Reinecke, A., & Harmer, C. J. (2013) · Psychological Medicine · doi:10.1017/s0033291713000731 · Cited by 66 · see citing works

A Randomized Trial on the Acute and Steady-State Effects of a New Antidepressant, Vortioxetine (Lu AA21004), on Actual Driving and Cognition

Theunissen, E. L., Street, D., Højer, A.-M., Vermeeren, A., Oers, A. C. M. V., & Ramaekers, J. G. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.39 · Cited by 64 · see citing works

Modulation of the Critical Flicker Fusion effects of serotonin reuptake inhibitors by concomitant pupillary changes

Schmitt, J. A. J., Riedel, W. J., Vuurman, E. F. P. M., Kruizinga, M. J., & Ramaekers, J. G. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0993-y · Cited by 64 · see citing works

Selective serotonin reuptake inhibitors: Their effect on high-intensity exercise performance

Parise, G., Bosman, M. J., Boecker, D. R., Barry, M. J., & Tarnopolsky, M. A. (2001) · Archives of Physical Medicine and Rehabilitation · doi:10.1053/apmr.2001.23275 · Cited by 63 · see citing works

Effect of paroxetine and nefazodone on 5-HT 1A receptor sensitivity

Sargent, P. A., Williamson, D. J., Pearson, G., Odontiadis, J., & Cowen, P. J. (1997) · Psychopharmacology · doi:10.1007/s002130050348 · Cited by 61 · see citing works

Differential effects of amitriptyline, nefazodone and paroxetine on performance and brain indices of visual selective attention and working memory

van Laar, M., Volkerts, E. R., Verbaten, M. N., Trooster, S., van Megen, H. J. G. M., & Kenemans, J. L. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1116-0 · Cited by 57 · see citing works

The CONSORT Statement: Application within and adaptations for orthodontic trials

Pandis, N., Fleming, P. S., Hopewell, S., & Altman, D. G. (2015) · American Journal of Orthodontics and Dentofacial Orthopedics · doi:10.1016/j.ajodo.2015.03.014 · Cited by 54 · see citing works

Gray matter and intrinsic network changes in the posterior cingulate cortex after selective serotonin reuptake inhibitor intake

Kraus, C., Ganger, S., Losak, J., Hahn, A., Savli, M., Kranz, G. S., Baldinger, P., Windischberger, C., Kasper, S., & Lanzenberger, R. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2013.08.036 · Cited by 54 · see citing works

Modulation of Frontostriatal Interaction Aligns with Reduced Primary Reward Processing under Serotonergic Drugs

Abler, B., Grön, G., Hartmann, A., Metzger, C. D., & Walter, M. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5826-11.2012 · Cited by 53 · see citing works

Effects of a Selective Serotonin Reuptake Inhibitor, Fluoxetine, on Counterregulatory Responses to Hypoglycemia in Healthy Individuals

Briscoe, V. J., Ertl, A. C., Tate, D. B., Dawling, S., & Davis, S. N. (2008) · Diabetes · doi:10.2337/db08-0236 · Cited by 52 · see citing works

Longitudinal effects of the SSRI paroxetine on salivary cortisol in Major Depressive Disorder

Ruhé, H. G., Khoenkhoen, S. J., Ottenhof, K., Koeter, M. W. J., Mocking, R. J. T., & Schene, A. H. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.10.024 · Cited by 49 · see citing works

Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR spectroscopy

Taylor, M. J., Murphy, S. E., Selvaraj, S., Wylezinkska, M., Jezzard, P., Cowen, P. J., & Evans, J. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107081510 · Cited by 44 · see citing works

Effect of fluoxetine, pemoline and placebo on heart period and QT variability in normal humans

Pohl, R. B., Balon, R., Jayaraman, A., Doll, R. G., & Yeragani, V. K. (2003) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00478-6 · Cited by 43 · see citing works

(S)-citalopram influences amygdala modulation in healthy subjects: a randomized placebo-controlled double-blind fMRI study using dynamic causal modeling

Sladky, R., Spies, M., Hoffmann, A., Kranz, G. S., Hummer, A., Gryglewski, G., Lanzenberger, R. R., Windischberger, C., & Kasper, S. F. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.12.044 · Cited by 43 · see citing works

Using an Experimental Medicine Model to Explore Combination Effects of Pharmacological and Cognitive Interventions for Depression and Anxiety

Browning, M., Grol, M., Ly, V., Goodwin, G. M., Holmes, E. A., & Harmer, C. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.159 · Cited by 42 · see citing works

Two weeks of pretreatment with escitalopram facilitates extinction learning in healthy individuals

Bui, E., Orr, S. P., Jacoby, R. J., Keshaviah, A., LeBlanc, N. J., Milad, M. R., Pollack, M. H., & Simon, N. M. (2013) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2330 · Cited by 42 · see citing works

The Effects of Citalopram and Fluoxetine on Sexual Behavior in Healthy Men: Evidence of Delayed Ejaculation and Unaffected Sexual Desire. A Randomized, Placebo-Controlled, Double-Blind, Double-Dummy, Parallel Group Study

Madeo, B., Bettica, P. U., Milleri, S., Antonio, B., Granata, A. R. M., Carani, C., & Rochira, V. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.00843.x · Cited by 40 · see citing works

Serotonergic involvement in the psychosocial dimension of personality

Tse, W. S., & Bond, A. J. (2001) · Journal of Psychopharmacology · doi:10.1177/026988110101500313 · Cited by 39 · see citing works

Paroxetine-induced modulation of cortical activity supporting language representations of action

Péran, P., Démonet, J., & Cardebat, D. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0939-0 · Cited by 36 · see citing works

Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale

Montejo, A. L., Deakin, J. F. W., Raphaël Gaillard, B., Harmer, C. J., Meyniel, F., Jabourian, A. P., Gabriel, C., Gruget, C., Klinge, C., MacFayden, C., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115599385 · Cited by 35 · see citing works

Chronic modulation of serotonergic neurotransmission with sertraline attenuates the loudness dependence of the auditory evoked potential in healthy participants

Simmons, J. G., Nathan, P. J., Berger, G. E., & Allen, N. B. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2265-9 · Cited by 33 · see citing works

Altered reward processing in the orbitofrontal cortex and hippocampus in healthy first-degree relatives of patients with depression

Macoveanu, J., Knorr, U. B., Skimminge, A., Soendergaard, M. G., Jørgensen, A., Faurholt‐Jepsen, M., Paulson, O. B., Knudsen, G. M., Siebner, H. R., & Kessing, L. V. (2013) · Psychological Medicine · doi:10.1017/s0033291713001815 · Cited by 32 · see citing works

Effects of 5 weeks of administration of fluoxetine and dothiepin in normal volunteers on sleep, daytime sedation, psychomotor performance and mood

Wilson, S. J., Bailey, J., Alford, C., et al. (2002) · Journal of Psychopharmacology · doi:10.1177/026988110201600406 · Cited by 29 · see citing works

Differential effects of escitalopram on attention: a placebo-controlled, double-blind cross-over study

Drueke, B., Baetz, J., Boecker, M., Moeller, O., Hiemke, C., Gründer, G., & Gauggel, S. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1649-6 · Cited by 29 · see citing works

The effect of selective serotonin reuptake inhibitors in healthy subjects. A systematic review

Knorr, U. B., & Kessing, L. V. (2010) · Nordic Journal of Psychiatry · doi:10.3109/08039480903511381 · Cited by 29 · see citing works

Early Effects of Paroxetine on Serotonin Storage, Plasma Levels, and Urinary Excretion

Kotzailias, N., Marker, M., & Jilma, B. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000138765.08235.46 · Cited by 27 · see citing works

‘Can you look me in the face?’ Short-term SSRI Administration Reverts Avoidant Ocular Face Exploration in Subjects at Risk for Psychopathology

Simplicio, M. C. D., Doallo, S., Costoloni, G., Rohenkohl, G., Nobre, A. C., & Harmer, C. J. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.159 · Cited by 26 · see citing works

Effect of paroxetine and bupropion on human resting brain perfusion: An arterial spin labeling study

Viviani, R., Abler, B., Seeringer, A., & Stingl, J. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.03.014 · Cited by 25 · see citing works

Serotonergic modulation of response inhibition and re‐engagement? Results of a study in healthy human volunteers

Drueke, B., Boecker, M., Schlaegel, S. M. A., Moeller, O., Hiemke, C., Gründer, G., & Gauggel, S. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1141 · Cited by 25 · see citing works

Fluctuations in [11C]SB207145 PET Binding Associated with Change in Threat-Related Amygdala Reactivity in Humans

Fisher, P. M., Haahr, M. E., Jensen, C. G., Frøkjær, V. G., Siebner, H. R., & Knudsen, G. M. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.339 · Cited by 25 · see citing works

Escitalopram attenuates posterior cingulate activity during self-evaluation in healthy volunteers

Matthews, S. C., Simmons, A. N., Strigo, I. A., Arce, E., Stein, M. B., & Paulus, M. P. (2010) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2010.02.003 · Cited by 25 · see citing works

Effects of Desipramine and Escitalopram on Postprandial Symptoms Induced by the Nutrient Drink Test in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled Study

Talley, N. J., Camilleri, M., Chitkara, D. K., Bouras, E. P., Locke, G. R., Burton, D. D., Rucker, M. J., Thapa, P. B., & Zinsmeister, A. R. (2005) · Digestion · doi:10.1159/000088363 · Cited by 24 · see citing works

Effects of selective serotonin reuptake inhibition on neural activity related to risky decisions and monetary rewards in healthy males

Macoveanu, J., Fisher, P. M., Haahr, M. E., Frøkjær, V. G., Knudsen, G. M., & Siebner, H. R. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.05.040 · Cited by 22 · see citing works

The effect of escitalopram versus placebo on perceived stress and salivary cortisol in healthy first-degree relatives of patients with depression—A randomised trial

Knorr, U. B., Vinberg, M., Gether, U., Winkel, P., Gluud, C. N., Wetterslev, J., & Kessing, L. V. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.05.015 · Cited by 21 · see citing works

The selective serotonin re-uptake inhibitor escitalopram modulates the panic response to cholecystokinin tetrapeptide in healthy men depending on 5-HTTLPR genotype

Kellner, M. B., Muhtz, C., Demiralay, C., Husemann, J., Koelsch, W., Yassouridis, A., & Wiedemann, K. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.09.001 · Cited by 21 · see citing works

Lack of effect of citalopram on magnetic resonance spectroscopy measures of glutamate and glutamine in frontal cortex of healthy volunteers

Taylor, M., Norbury, R., Murphy, S. E., Rudebeck, S. R., Jezzard, P., & Cowen, P. J. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109105679 · Cited by 21 · see citing works

A comparative study of the interactions of alcohol with amitriptyline, fluoxetine and placebo in normal subjects

Allen, D. N., LADER, M. H., & Curran, H. V. (1988) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(88)90062-0 · Cited by 21 · see citing works

Effects of vilazodone on sexual functioning in healthy adults

Clayton, A. H., Durgam, S., Li, D., Chen, C., Chen, L., Mathews, M., Gommoll, C., & Szegedi, A. (2016) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000145 · Cited by 21 · see citing works

SSRI effects on pyschomotor performance: assessment of citalopram and escitalopram on normal subjects.

Paul, M. A., Gray, G. W., Love, R. J., & Lange, M. (2007) · PubMed · Cited by 20 · see citing works

Translating depression biomarkers for improved targeted therapies

Bredt, D. S., Furey, M. L., Chen, G., Lovenberg, T., Drevets, W. C., & Manji, H. K. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.09.013 · Cited by 20 · see citing works

No evidence for an anti-inflammatory effect of escitalopram intervention in healthy individuals with a family history of depression

Haastrup, E. K., Knorr, U. B., Erikstrup, C., Kessing, L. V., & Ullum, H. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.12.006 · Cited by 19 · see citing works

Verbal memory performance during subchronic challenge with a selective serotonergic and a mixed action antidepressant

Wingen, M., Langer, S. W., & Ramaekers, J. G. (2006) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.800 · Cited by 19 · see citing works

Immune Disturbances in Treatment-Resistant Depression: Modulation by Antidepressive Treatments

Maes, M. H. J., Vandoolaeghe, E., Hunsel, F. V., Bril, T., Demedts, P., Wauters, A., & Neels, H. M. (1997) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199703/04)12:2 · Cited by 19 · see citing works

Enhancement of stress-induced pituitary hormone release and cardiovascular activation by antidepressant treatment in healthy men

Ježová, D., & Dunčko, R. (2002) · Journal of Psychopharmacology · doi:10.1177/026988110201600308 · Cited by 19 · see citing works

Modulation of attention network activation under antidepressant agents in healthy subjects

Graf, H., Abler, B., Hartmann, A., Metzger, C. D., & Walter, M. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001368 · Cited by 17 · see citing works

The impact of sertraline on psychomotor performance.

Paul, M. A., Gray, G. W., & Lange, M. (2002) · PubMed · Cited by 17 · see citing works

Acute citalopram administration may disrupt contextual information processing in healthy males

Almeida, S. S., Glahn, D. C., Argyropoulos, S., & Frangou, S. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2009.05.010 · Cited by 14 · see citing works

SSRI enhances sensitivity to background outcomes and modulates response rates: A randomized double blind study of instrumental action and depression

Msetfi, R. M., Kumar, P., Harmer, C. J., & Murphy, R. A. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.03.004 · Cited by 14 · see citing works

Mood and personality effects in healthy participants after chronic administration of sertraline

Simmons, J. G., & Allen, N. B. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.06.007 · Cited by 12 · see citing works

Serotonergic antidepressants decrease hedonic signals but leave learning signals in the nucleus accumbens unaffected

Graf, H., Metzger, C. D., Walter, M., & Abler, B. (2015) · Neuroreport · doi:10.1097/wnr.0000000000000487 · Cited by 12 · see citing works

Decreased recognition of negative affect after selective serotonin reuptake inhibition is dependent on genotype

Hinkelmann, K., Dragoi, L., Gompf, J., Muhtz, C., Demiralay, C., Yassouridis, A., Wiedemann, K., & Kellner, M. B. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.03.008 · Cited by 11 · see citing works

The effect of 6-week treatment with escitalopram on CCK-4 challenge: A placebo-controlled study in CCK-4-sensitive healthy volunteers

Tõru, I., Maron, E., Raag, M., et al. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.08.011 · Cited by 10 · see citing works

No effect of six weeks of treatment with escitalopram on mood in healthy volunteers — Irrespective of genotype for the promoter of the serotonin transporter

Kellner, M. B., Demiralay, C., Muhtz, C., et al. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2008.04.025 · Cited by 10 · see citing works

Preliminary evidence that sub-chronic citalopram triggers the re-evaluation of value in intimate partnerships

Bilderbeck, A. C., Wakeley, J., Godlewska, B. R., McGlone, F. P., Harris, T., Cowen, P. J., & Rogers, R. D. (2013) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nst135 · Cited by 10 · see citing works

A placebo-controlled study of sertraline’s effect on cortisol response to the dexamethasone/corticotropin-releasing hormone test in healthy adults

Carpenter, L., Tyrka, A., Lee, J. K., Tracy, A. P., Wilkinson, C. W., & Price, L. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2336-y · Cited by 8 · see citing works

A randomized trial of the effect of escitalopram versus placebo on cognitive function in healthy first-degree relatives of patients with depression

Knorr, U. B., Vinberg, M., Gade, A., Winkel, P., Gluud, C. N., Wetterslev, J., Gether, U., & Kessing, L. V. (2011) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125311422591 · Cited by 8 · see citing works

Effect of escitalopram versus placebo on GRα messenger RNA expression in peripheral blood cells of healthy individuals with a family history of depression – a secondary outcome analysis from the randomized AGENDA trial

Knorr, U., Koefoed, P., Gluud, C. N., Wetterslev, J., Winkel, P., Gether, U., Vinberg, M., & Kessing, L. V. (2016) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2015.1109138 · Cited by 8 · see citing works

No effect of escitalopram versus placebo on brain-derived neurotrophic factor in healthy individuals: a randomised trial

Knorr, U. B., Koefoed, P., Soendergaard, M. G., Vinberg, M., Gether, U., Gluud, C. N., Wetterslev, J., Winkel, P., & Kessing, L. V. (2015) · Acta Neuropsychiatrica · doi:10.1017/neu.2015.55 · Cited by 7 · see citing works

Effects of paroxetine on emotional functioning and treatment awareness: a 4-week randomized placebo-controlled study in healthy clinicians

Besnier, N., Cassé‐Perrot, C., Jouve, É., Nguyen, N. P. T., Lançon, C., Falissard, B., & Blin, O. J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1691-4 · Cited by 6 · see citing works

Paying attention to attention in depression

Keller, A. S., Leikauf, J. E., Holt-Gosselin, B., Staveland, B. R., & Williams, L. M. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0616-1 · Cited by 329 · see citing works

Domestic clinical applications of fluoxetine during 10 years

Dai-hui, P. (2005) · Chinese Journal of New Drugs and Clinical Remedies

Seizures associated with fluoxetine therapy

Prasher, V. P. (1993) · Seizure · doi:10.1016/s1059-1311(05)80148-7 · Cited by 30 · see citing works

Meta-ananlysis of Comparative Study on Fluoxetine in the Treatment of Obsessive-compulsive Disorder

Chang-qu, C. (2012) · Chinese Journal of Clinical Rational Drug Use

Decreased Aggressive and Locomotor Behaviors in <i>Betta Splendens</i> after Exposure to Fluoxetine

Kohlert, J. G., Mangan, B. P., Kodra, C., et al. (2012) · Psychological Reports · doi:10.2466/02.13.pr0.110.1.51-62 · Cited by 74 · see citing works

선택적 세로토닌 재흡수 차단제인 fluoxetine 이 우울증을 야기시킨 쥐의 수동적 회피 학습에 미치는 영향

조선영, 이기철, 이정호, et al. (1996) · 한국심리학회지: 인지 및 생물